Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality 29% Improvement Relative Risk Vitamin D for COVID-19  Pimental et al.  ICU PATIENTS Are vitamin D levels associated with COVID-19 outcomes? Retrospective 25 patients in Brazil Study underpowered to detect differences c19early.org Pimental et al., Clinical Nutrition ES.., May 2021 Favors vitamin D Favors control

Low vitamin D levels and increased neutrophil in patients admitted at ICU with COVID-19

Pimental et al., Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2021.05.021
May 2021  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 119 studies, recognized in 7 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,800+ studies for 60+ treatments. c19early.org
Retrospective 25 ICU patients in Brazil, showing vitamin D deficiency associated with higher neutrophil-lymphocyte ratio. There appears to be a typo in the mortality percentage for vitamin D deficiency (20% is not valid for the group size of 8).
This is the 70th of 192 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 611 vigintillion).
risk of death, 29.4% lower, RR 0.71, p = 1.00, high D levels 3 of 17 (17.6%), low D levels 2 of 8 (25.0%), NNT 14, >20ng/mL.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Pimental et al., 31 May 2021, retrospective, Brazil, peer-reviewed, 3 authors.
This PaperVitamin DAll
Low vitamin D levels and increased neutrophil in patients admitted at ICU with COVID-19
Gustavo D Pimentel, Maria C M Dela Vega, Claude Pichard
Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2021.05.021
Background & aims: Systemic inflammation has been reported as a new predictor for COVID-19 outcomes. Thus, we hypothesized that ICU patients infected by COVID-19 had lower blood vitamin D levels and increased systemic inflammation. Therefore, this is the first Brazilian study to evaluate the vitamin D concentrations and NLR as a systemic inflammation in patients infected by COVID-19 admitted in ICU. Methods: This cross-sectional study selected twenty-six patients from COVID-19 Data Sharing/FAPESP, Brazil. Twenty-five patients were enrolled from a single hospital and those with blood vitamin D and neutrophil and lymphocyte data were included and had all available data analyzed. Patients were divided in two groups: low vitamin D concentration when 20 ng/mL (low Vit D group, n ¼ 8, 5M/3F, 62.7 ± 8.4 years old), and normal vitamin D when > 20 ng/mL (normal Vit D group, n ¼ 17, 9M/8F, 74 ± 8.2 years old). Serum 25-hydroxy-vitamin D, C reactive protein (CRP), and count of neutrophils and lymphocytes concentrations were collected from COVID-19 Data Sharing/FAPESP. Statistical analyses were performed using the Prism version 5.0 and Student T test was applied to verify any difference between the groups. Results: Low vitamin D group had 15.5 ± 3.3 ng/mL of 25OH Vit D concentrations and normal vitamin D group had 35.9 ± 8.8 ng/mL. Although no difference between groups for CRP concentrations (low Vit D: 4.5 ± 3.3 vs. normal Vit D: 4.2 ± 4.0 mg/dL, p ¼ 0.45), we found higher neutrophil count and NLR values in the low Vit D group when compared to normal Vit D group (low Vit D: 6049.8 ± 3719.7 vs. normal Vit D: 3741.8 ± 1704.1 ng/mL, p ¼ 0.02) and (low Vit D: 9.0 ± 8.6 vs. normal Vit D: 4.2 ± 4.0 ng/mL, p ¼ 0.03), respectively. Conclusion: This data sharing-derived cases of COVID-19 in patients admitted at ICU showed that patients infected by COVID-19 had lower serum 25-hydroxy vitamin D and enhanced systemic inflammation when assessed by NLR values.
Authorship GDP, MCMDV, and CP wrote the article and approved the final version of this manuscript. Funding No funding was received for this work. Declaration of competing interest None declared.
References
Ali, Role of vitamin D in preventing of COVID-19 infection, progression and severity, J Infect Publ Health, doi:10.1016/j.jiph.2020.06.021
Bergman, The link between Vitamin D and Covid-19: distinguishing facts from fiction, J Intern Med, doi:10.1111/joim.13158
Biesalski, Obesity, vitamin D deficiency and old age a serious combination with respect to coronavirus disease-2019 severity and outcome, Curr Opin Clin Nutr Metab Care, doi:10.1097/MCO.0000000000000700
Daoust, Pilon, Marette, Perspective: nutritional strategies targeting the gut microbiome to mitigate COVID-19 outcomes, Adv Nutr, doi:10.1093/advances/nmab031
Evans, Lippman, Shining light on the COVID-19 pandemic: a vitamin D receptor checkpoint in defense of unregulated wound healing, Cell Metabol, doi:10.1016/j.cmet.2020.09.007
Gomes, Fernandes, Vieira, Schincaglia, Mota et al., Low vitamin D at ICU admission is associated with cancer, infections, acute respiratory insufficiency, and liver failure, Nutrition, doi:10.1016/j.nut.2018.10.018
Kaufman, Niles, Kroll, Bi, Holick, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PloS One, doi:10.1371/journal.pone.0239252
Liao, Zhou, Luo, Xu, Wang et al., Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study, Lancet Haematol, doi:10.1016/S2352-3026(20)30217-9
Liu, Du, Chen, Jin, Peng et al., Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19, J Infect, doi:10.1016/j.jinf.2020.04.002
Pimentel, Vega, Laviano, High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients, Clin Nutr ESPEN, doi:10.1016/j.clnesp.2020.08.004
Richardson, Hirsch, Narasimhan, Crawford, Mcginn et al., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area, Jama, doi:10.1001/jama.2020.6775
Richardson, Lovegrove, Nutritional status of micronutrients as a possible and modifiable risk factor for COVID-19: a UK perspective, Br J Nutr, doi:10.1017/S000711452000330X
Wiersinga, Rhodes, Cheng, Peacock, Prescott, Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review, JAMA, doi:10.1001/jama.2020.12839
Zhou, Luo, Qin, The association between vitamin D deficiency and community-acquired pneumonia: a meta-analysis of observational studies, Medicine, doi:10.1097/MD.000000000001725
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit